|Articles|October 18, 2021

This week on Contemporary OB/GYN®: Oct. 18 to Oct. 22

Here's what to look for this week on Contemporary OB/GYN®.

This week's topics include:

Diagnosing and treating vaginal discharge

Inappropriate treatment is widespread among women with vaginitis symptoms, according to a study conducted in a community practice setting.

Moderna, Johnson and Johnson COVID-19 boosters recommended by FDA

The advisory panel is also scheduled to discuss Merck antiviral pill late next month.

Changes in menstrual cycle length could signal increased risk of atherosclerosis

Using data from SWAN DHS, investigators determined changes in menstrual cycle length prior to a woman's final menstrual period were associated with changes in carotid intima-media thickness and brachial-ankle pulse wave velocity.

Combined contraceptive pills may reduce risk of diabetes in PCOS

A pair of studies provide insight into the increased risk of dysglycemia among women with PCOS and the potential influence of combined oral contraceptive pills on this risk in a population-based cohort.

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related to this article

October 29th, 2026

Susan Reed, MD, on the future of menopause research and funding

Susan Reed, MD, on the need for menopause research funding, a clinical trials network, and studies in understudied groups and perimenopause.

October 29th, 2026

Chrisandra Shufelt, MD, on cardiovascular prevention at menopause

Chrisandra Shufelt, MD, on why menopause is a window for cardiovascular prevention and the risk factors OB/GYNs should assess.

October 28th, 2026

Matthew Nudy, MD, on estrogen and the cardiovascular system

Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.

October 28th, 2026

ACOG advises against GLP-1 receptor agonists during pregnancy

ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.

October 27th, 2026

Rhonda Voskuhl, MD, on estriol for cognitive symptoms of menopause

Rhonda Voskuhl, MD, on a case series in which estriol and progesterone improved self-reported cognition in menopausal women at 12 months.

October 27th, 2026

Multi-society framework ties cardiovascular risk to female life stages

Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.

October 26th, 2026

Mind, Body, & the Pause: Menopause, brain fog, and screening gaps, with Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG

In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.